These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26631113)

  • 1. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
    Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
    Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
    Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
    Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the transcription factor Myb by small-molecule inhibitors.
    Uttarkar S; Frampton J; Klempnauer KH
    Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.
    Yusenko MV; Biyanee A; Andersson MK; Radetzki S; von Kries JP; Stenman G; Klempnauer KH
    Cancer Lett; 2021 Nov; 520():132-142. PubMed ID: 34256093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.
    Yusenko MV; Trentmann A; Andersson MK; Ghani LA; Jakobs A; Arteaga Paz MF; Mikesch JH; Peter von Kries J; Stenman G; Klempnauer KH
    Cancer Lett; 2020 Jun; 479():61-70. PubMed ID: 32014461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYB as a Critical Transcription Factor and Potential Therapeutic Target in AML.
    Clarke ML; Gabrielsen OS; Frampton J
    Adv Exp Med Biol; 2024; 1459():341-358. PubMed ID: 39017851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
    Pattabiraman DR; Sun J; Dowhan DH; Ishii S; Gonda TJ
    Mol Cancer Res; 2009 Sep; 7(9):1477-86. PubMed ID: 19737967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.
    Schmidt TJ; Klempnauer KH
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity.
    Yusenko M; Jakobs A; Klempnauer KH
    Sci Rep; 2018 Sep; 8(1):13159. PubMed ID: 30177851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dual-Site Inhibitor of CBP/p300 KIX is a Selective and Effective Modulator of Myb.
    Joy ST; Henley MJ; De Salle SN; Beyersdorf MS; Vock IW; Huldin AJL; Mapp AK
    J Am Chem Soc; 2021 Sep; 143(37):15056-15062. PubMed ID: 34491719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
    Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
    Elife; 2021 Feb; 10():. PubMed ID: 33527899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidomimetic blockade of MYB in acute myeloid leukemia.
    Ramaswamy K; Forbes L; Minuesa G; Gindin T; Brown F; Kharas MG; Krivtsov AV; Armstrong SA; Still E; de Stanchina E; Knoechel B; Koche R; Kentsis A
    Nat Commun; 2018 Jan; 9(1):110. PubMed ID: 29317678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner.
    Biyanee A; Yusenko MV; Klempnauer KH
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemia.
    Zhao H; Jin S; Gewirtz AM
    J Biol Chem; 2012 Jan; 287(2):925-34. PubMed ID: 22110127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
    Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
    Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.